Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma
{{output}}
Background/aim: Neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (NAC-DCF) is the standard treatment for locally advanced esophageal squamous cell cancer (ESCC) in Japan; however, reliable markers for early ... ...
